Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.
Gómez E, Montero JL, Molina E, García-Buey L, Casado M, Fuentes J, Simón MA, Díaz-González A, Jorquera F, Morillas RM, Presa J, Berenguer M, Conde MI, Olveira A, Macedo G, Garrido I, Hernández-Guerra M, Olivas I, Rodríguez-Tajes S, Londoño M, Sousa JM, Ampuero J, Romero-González E, González-Padilla S, Escudero-García D, Carvalho A, Santos A, Gutiérrez ML, Pérez-Fernández E, Aburruza L, Uriz J, Gomes D, Santos L, Martínez-González J, Albillos A, Fernández-Rodríguez CM. Gómez E, et al. Among authors: olveira a. Aliment Pharmacol Ther. 2024 Jun;59(12):1604-1615. doi: 10.1111/apt.18004. Epub 2024 May 1. Aliment Pharmacol Ther. 2024. PMID: 38690746
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.
Alonso S, Riveiro-Barciela M, Fernandez I, Rincón D, Real Y, Llerena S, Gea F, Olveira A, Fernandez-Carrillo C, Polo B, Carrión JA, Gómez A, Devesa MJ, Baliellas C, Castro Á, Ampuero J, Granados R, Pascasio JM, Rubín A, Salmeron J, Badia E, Planas JM, Lens S, Turnes J, Montero JL, Buti M, Esteban R, Fernández-Rodríguez CM. Alonso S, et al. Among authors: olveira a. J Viral Hepat. 2017 Apr;24(4):304-311. doi: 10.1111/jvh.12648. Epub 2016 Dec 9. J Viral Hepat. 2017. PMID: 27935168 Free article.
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort.
Puigvehí M, De Cuenca B, Viu A, Diago M, Turnes J, Gea F, Pascasio JM, Lens S, Cabezas J, Badia E, Olveira A, Morillas RM, Torras X, Montoliu S, Cordero P, Castro JL, Salmerón J, Molina E, Sánchez-Ruano JJ, Moreno J, Antón MD, Moreno JM, De la Vega J, Calleja JL, Carrión JA. Puigvehí M, et al. Among authors: olveira a. Liver Int. 2019 Jan;39(1):90-97. doi: 10.1111/liv.13950. Epub 2018 Nov 12. Liver Int. 2019. PMID: 30160363
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.
Alonso López S, Manzano ML, Gea F, Gutiérrez ML, Ahumada AM, Devesa MJ, Olveira A, Polo BA, Márquez L, Fernández I, Cobo JCR, Rayón L, Riado D, Izquierdo S, Usón C, Real Y, Rincón D, Fernández-Rodríguez CM, Bañares R. Alonso López S, et al. Among authors: olveira a. Hepatology. 2020 Dec;72(6):1924-1934. doi: 10.1002/hep.31588. Epub 2020 Nov 10. Hepatology. 2020. PMID: 33022803
Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid.
Gomez E, Garcia Buey L, Molina E, Casado M, Conde I, Berenguer M, Jorquera F, Simón MA, Olveira A, Hernández-Guerra M, Mesquita M, Presa J, Costa-Moreira P, Macedo G, Arenas JI, Manuel Sousa J, Ampuero J, Morillas RM, Santos A, De Carvalho A, Uriz J, Carrión JA, Luisa Gutiérrez M, Pérez-Fernández E, Fernández-Rodríguez CM; IBER-PBC leading Cooperative Group. Gomez E, et al. Among authors: olveira a. Aliment Pharmacol Ther. 2021 Feb;53(4):519-530. doi: 10.1111/apt.16181. Epub 2020 Dec 12. Aliment Pharmacol Ther. 2021. PMID: 33314220
Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals.
Sánchez-Azofra M, Fernández I, García-Buey ML, Domínguez-Domínguez L, Fernández-Rodríguez CM, Mancebo A, Bonet L, Ryan P, Gea F, Díaz-Sánchez A, García-Mayor M, Martín-Carbonero L, Castillo P, Manzano ML, González-Moreno L, Pulido F, Gutiérrez ML, Moreno JM, García-Amengual IM, Cuevas G, Guerrero A, Rivero-Fernández M, Portales ME, Montes ML, Olveira A. Sánchez-Azofra M, et al. Among authors: olveira a. Liver Int. 2021 Dec;41(12):2885-2891. doi: 10.1111/liv.15032. Epub 2021 Aug 24. Liver Int. 2021. PMID: 34392590
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study.
Téllez L, Sánchez Rodríguez E, Rodríguez de Santiago E, Llovet L, Gómez-Outomuro A, Díaz-Fontenla F, Álvarez López P, García-Eliz M, Amaral C, Sánchez-Torrijos Y, Fortea JI, Ferre-Aracil C, Rodríguez-Perálvarez M, Abadía M, Gómez-Camarero J, Olveira A, Calleja JL, Crespo J, Romero M, Hernández-Guerra M, Berenguer M, Riveiro-Barciela M, Salcedo M, Rodríguez M, Londoño MC, Albillos A. Téllez L, et al. Among authors: olveira a. Aliment Pharmacol Ther. 2022 Jul;56(1):131-143. doi: 10.1111/apt.16926. Epub 2022 Apr 25. Aliment Pharmacol Ther. 2022. PMID: 35470447 Free PMC article.
AEEH «Consensus about detection and referral of hidden prevalent liver diseases».
Romero-Gómez M, Aller R, Ampuero J, Fernández Rodríguez C, Augustín S, Latorre R, Rivera-Esteban J, Martínez Urroz B, Gutiérrez García ML, López SA, Albillos A, Hernández M, Graupera I, Benlloch S, Olveira A, Crespo J, Calleja JL. Romero-Gómez M, et al. Among authors: olveira a. Gastroenterol Hepatol. 2023 Mar;46(3):236-247. doi: 10.1016/j.gastrohep.2022.04.001. Epub 2022 May 13. Gastroenterol Hepatol. 2023. PMID: 35569541 English, Spanish. No abstract available.
68 results